First Citizens Bank & Trust CO Vertex Pharmaceuticals Inc Transaction History
First Citizens Bank & Trust CO
- $5.9 Billion
- Q1 2025
A detailed history of First Citizens Bank & Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Citizens Bank & Trust CO holds 4,197 shares of VRTX stock, worth $2.06 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,197
Previous 4,836
13.21%
Holding current value
$2.06 Million
Previous $1.95 Million
4.47%
% of portfolio
0.03%
Previous 0.03%
Shares
28 transactions
Others Institutions Holding VRTX
# of Institutions
1,782Shares Held
224MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.9 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.4 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.5 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.88 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.12 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $126B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...